BullishBiopharmaPro11/28/19, 12:45 AM$PTI A good read for everyone even those who have CF, 42% of patients have not taken a CFTR modulator therapy. That's shocking that so many patients still don't have access to a specific CFTR therapy. biospace.com/article/survey...116